Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease

  • 1.

    2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 16, 391–460 (2020).

  • 2.

    Musiek, E. S. & Holtzman, D. M. Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’. Nat. Neurosci. 18, 800–806 (2015).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    De Strooper, B. & Karran, E. The cellular phase of Alzheimer’s disease. Cell 164, 603–615 (2016).

    PubMed 

    Google Scholar
     

  • 4.

    Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312–339 (2019).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Ittner, L. M. & Götz, J. Amyloid-β and tau—a toxic pas de deux in Alzheimer’s disease. Nat. Rev. Neurosci. 12, 65–72 (2011).

    CAS 
    PubMed 

  • Read more…